| Followers | 6 |
| Posts | 1045 |
| Boards Moderated | 0 |
| Alias Born | 09/06/2003 |
Thursday, August 21, 2014 6:16:52 PM
Very impressive situation
Huge market, just met CEO
Real deal, clearly have their act together!
Huge market, just met CEO
Real deal, clearly have their act together!
Recent DYAI News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2026 01:56:17 AM
- Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 03/25/2026 08:51:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:14:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:13:15 PM
- Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices • GlobeNewswire Inc. • 03/16/2026 11:20:00 AM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 • GlobeNewswire Inc. • 03/11/2026 08:10:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 10:04:30 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:02:34 PM
- Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) • GlobeNewswire Inc. • 03/04/2026 12:20:00 PM
- Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone • GlobeNewswire Inc. • 03/02/2026 12:20:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:14:24 PM
- Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin • GlobeNewswire Inc. • 02/17/2026 12:25:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:12:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:11:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:10:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:08:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:07:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:05:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:04:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2025 09:00:40 PM
- Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets • GlobeNewswire Inc. • 12/17/2025 12:20:00 PM
- Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins • GlobeNewswire Inc. • 12/15/2025 12:20:00 PM
- Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 • ACCESS Newswire • 12/08/2025 02:00:00 PM
